The "contraceptive revolution" of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen? Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments. The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda." Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.
"synopsis" may belong to another edition of this title.
Polly F. Harrison and Allan Rosenfield, Editors; Committee on Contraceptive Research and Development, Institute of Medicine
Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments. The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda". Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.
"About this title" may belong to another edition of this title.
Seller: Banjo Booksellers, IOBA, Andover, MA, U.S.A.
Hardcover. Condition: Fine. No Jacket. First Edition. First printing (no additional printings listed). Also included is a 27-page pamphlet labelled "Summary", with the same front cover artwork as the main volume. Size: 8vo - over 7¾" - 9¾" tall. Seller Inventory # 002987
Seller: monobooks, Waterford, MI, U.S.A.
Hardcover. Condition: New. No Jacket. 1st Edition. First edition 1996, matching dates on title and copyright pages, no additional printings listed. Published for Institute of Medicine by National Academy Press. Hard cover in laminated boards without DJ as issued. Condition new, square tight and crisp book, spine not creased, sharp corners, bright and shiny, no edgewear, no markings of any kind, no names, no underlinings, no highlights, not a reminder. 8vo, 519 pages. Heavy book will require additional postage for international orders. Seller Inventory # 000379